Mouta N. De Oliveira
Fiocruz, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Inherited IFNAR1 structural deficiency in severe adverse events following yellow fever vaccination.
Journal: Clinical immunology (Orlando, Fla.)
Published: March 19, 2026
Pharmacovigilance capacity and readiness of vaccine manufacturers in low- and middle-income countries: a maturity-based assessment of the pharmacovigilance system.
Journal: Vaccine
Published: December 16, 2025
A cohort study of the duration of immunity to yellow fever after 4 years of primary vaccination in children and adults.
Journal: Transactions of the Royal Society of Tropical Medicine and Hygiene
Published: November 27, 2025
Active vaccine safety surveillance in low- and middle-income countries: Challenges for vaccine manufacturers from emerging countries.
Journal: Vaccine
Published: August 23, 2024
Immunogenicity of a single dose of the 17DD yellow fever vaccine in a cohort of adults and children in a non-endemic area, and its association with dengue and Zika seropositivity.
Journal: PLoS neglected tropical diseases
Published: May 17, 2024
Yellow Fever Vaccine-Associated Viscerotropic Disease among Siblings, São Paulo State, Brazil.
Journal: Emerging infectious diseases
Published: February 23, 2023
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.
Journal: The Journal of experimental medicine
Published: November 20, 2020
Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.
Journal: The Journal of experimental medicine
Published: December 12, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026